Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD

被引：9
作者：
Apte R.S. [1 ,2 ]
机构：
[1] Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110
[2] Barnes Retina Institute, Washington University School of Medicine, St. Louis, MO 63110
来源：
International Ophthalmology | 2007年 / 27卷 / 1期
关键词：
AMD; Intravitreal injections; Ranibizumab; RPE tear;
D O I：
10.1007/s10792-007-9066-5
中图分类号：
学科分类号：
摘要：
Purpose: To report a case of retinal pigment epithelial tear following intravitreal ranibizumab injection for subfoveal choroidal neovascularization. Methods: Retrospective single case review. Results: A 78-year-old Caucasian female was treated with intravitreal ranibizumab for occult subfoveal choroidal neovascularization (CNV) from age-related macular degeneration (AMD). She returned for evaluation with decreased vision and was found to have a retinal pigment epithelial tear on biomicroscopy. Fluorescein angiography and OCT testing confirmed the clinical findings. Conclusion: Although a pigment epithelial tear in neovascular AMD can represent natural history, prior reports of such tears after thermal laser, photodynamic therapy with verteporfin and following intravitreal injection of pegaptanib Na combined with this case report suggest that clinicians should be aware of and monitor patients for the possibility of this complication after intravitreal injections of ranibizumab. © Springer Science+Business Media, Inc. 2007.
引用
收藏
页码：59 / 61
页数：2
相关论文
共 9 条
  • [1] Gass J.D., Retinal pigment epithelial rip during krypton red laser photocoagulation, Am J Ophthalmol, 98, 6, pp. 700-706, (1984)
  • [2] Gelisken F., Inhoffen W., Partsch M., Schneider U., Kreissig I., Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization, Am J Ophthalmol, 131, 4, pp. 518-520, (2001)
  • [3] Dhalla M.S., Blinder K.J., Tewari A., Hariprasad S.M., Apte R.S., Retinal pigment epithelial tear following intravitreal pegaptanib sodium, Am J Ophthalmol, 141, 4, pp. 752-754, (2006)
  • [4] Gass J.D., Pathogenesis of tears of the retinal pigment epithelium, Br J Ophthalmol, 68, 8, pp. 513-519, (1984)
  • [5] Shah C.P., Hsu J., Garg S.J., Fischer D.H., Kaiser R., Retinal pigment epithelial tear after intravitreal bevacizumab injection, Am J Ophthalmol, 142, 6, pp. 1070-1072, (2006)
  • [6] Brown D.M., Kaiser P.K., Michels M., Soubrane G., Heier J.S., Kim R.Y., Sy J.P., Schneider S., Ranibizumab versus verteporfin for neovascular age-related macular degeneration, N Engl J Med, 355, 14, pp. 1432-1444, (2006)
  • [7] Rosenfeld P.J., Brown D.M., Heier J.S., Boyer D.S., Kaiser P.K., Chung C.Y., Kim R.Y., Ranibizumab for neovascular age-related macular degeneration, N Engl J Med, 355, 14, pp. 1419-1431, (2006)
  • [8] Coscas G., Koenig F., Soubrane G., The pretear characteristics of pigment epithelial detachments A study of 40 eyes, Arch Ophthalmol, 108, 12, pp. 1687-1693, (1990)
  • [9] Krishan N.R., Chandra S.R., Stevens T.S., Diagnosis and pathogenesis of retinal pigment epithelial tears, Am J Ophthalmol, 100, 5, pp. 698-707, (1985)
1